Fundraising Fox

Jupiter Orphan Therapeutics

NASDAQ: JUNS

Jupiter, US · Founded 2016 · Delaware corporation

Founders & leadership

JU
Jacob UittenbogaardChief Financial Officer, Treasurer and Secretary
MH
Marshall HaywardChief Scientific Officer
CR
Christer RosenChief Executive Officer and President
CW
Claes WahlestedtConsulting Chief Medical Officer

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 3 rounds · 2016–2017

$100KraisedDec 2017 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Marshall HaywardExecutive Officer, Director
  • Christer RosenExecutive Officer, Director
  • Natalie McNameeDirector
  • Claes WahlestedtExecutive Officer, Director
  • Jacob UittenbogaardExecutive Officer, Director
Offering amount
$100K
Amount sold
$100K
First sale
Nov 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1MraisedDec 2016 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Natalie McNameeDirector
  • Claes WahlestedtExecutive Officer, Director
  • Jacob UittenbogaardExecutive Officer, Director
  • Christer RosenExecutive Officer, Director
  • Marshall HaywardExecutive Officer, Director
Offering amount
$1M
Amount sold
$1M
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$250KraisedJul 2016 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jacob UittenbogaardExecutive Officer, Director
  • Marshall HaywardExecutive Officer, Director
  • Claes WahlestedtExecutive Officer, Director
  • Christer RosenExecutive Officer, Director
Offering amount
$4.5M
Amount sold
$250K
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$2M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

How much funding has Jupiter Orphan Therapeutics raised?
Jupiter Orphan Therapeutics has disclosed $1.4M raised across 3 rounds.
Where is Jupiter Orphan Therapeutics headquartered?
Jupiter Orphan Therapeutics is headquartered in Jupiter, US.